当前位置: X-MOL 学术Psychological Assessment › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Validation of DSM-5 clinician-rated measures of personality pathology.
Psychological Assessment ( IF 3.3 ) Pub Date : 2020-09-24 , DOI: 10.1037/pas0000960
Lena C Quilty 1 , R Michael Bagby 2 , Robert F Krueger 3 , Bruce G Pollock 1
Affiliation  

The American Psychiatric Association supported the development of several instruments to assess personality pathology according to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) Section III. These instruments include self- and informant report forms as well as clinician-rated measures of personality traits and impairment. To date, the psychometric properties of the DSM-5 Section III clinician-rated measures have received limited investigation. The objective of the current investigation was to evaluate the convergence between self-report and clinician-rated measures of DSM-5 personality pathology in a diagnostically heterogeneous psychiatric patient sample. A total of 201 outpatients with current psychiatric symptoms were recruited from a psychiatric hospital patient research registry. Participants completed both clinician-rated and self-reported measures of personality pathology. Self-reported personality traits converged with clinician-rated personality traits, with medium to large effect sizes. Current and Section III personality disorder criteria demonstrated significant convergence, most with medium to large effect sizes. Self-reported and clinician-rated personality impairment correlated with small to medium effect sizes. The current investigation incorporates a multi-informant assessment of personality in a psychiatric outpatient sample. These results provide evidence for the validity of the scores of the clinician-rated instruments used to implement this model. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

中文翻译:

验证DSM-5临床医生对人格病理的评估。

根据《精神障碍诊断和统计手册》(第5版; DSM-5)第三部分,美国精神病学协会支持开发几种评估人格病理的仪器。这些工具包括自我报告者和知情者报告表,以及临床医师对人格特质和损伤进行的评估。迄今为止,DSM-5第三节临床医师评定的措施的心理测量特性受到了有限的研究。当前研究的目的是评估诊断异质性精神病患者样本中自我报告与临床医师评估的DSM-5型人格病变之间的收敛性。从精神病医院患者研究登记处招募了总共201位当前有精神病症状的门诊患者。参加者完成了临床医师评定的和自我报告的人格病理学测量。自我报告的人格特质与临床医生评定的人格特质融合在一起,效果中等至大。当前和第三节的人格障碍标准显示出显着的收敛性,大多数具有中等到较大的影响程度。自我报告和临床医师评价的人格障碍与中小效应量相关。目前的研究纳入了精神科门诊样本中人格的多信息评估。这些结果为用于实施该模型的临床医师评定的仪器评分的有效性提供了证据。(PsycInfo数据库记录(c)2020 APA,保留所有权利)。自我报告的人格特质与临床医生评定的人格特质融合在一起,效果中等至大。当前和第三节的人格障碍标准显示出显着的收敛性,大多数具有中等到较大的影响程度。自我报告和临床医师评价的人格障碍与中小效应量相关。目前的研究纳入了精神科门诊样本中人格的多信息评估。这些结果为用于实施该模型的临床医师评定的仪器评分的有效性提供了证据。(PsycInfo数据库记录(c)2020 APA,保留所有权利)。自我报告的人格特质与临床医生评定的人格特质融合在一起,效果中等至大。当前和第三节的人格障碍标准显示出显着的收敛性,大多数具有中等到较大的影响程度。自我报告和临床医师评价的人格障碍与中小效应量相关。目前的研究纳入了精神科门诊样本中人格的多信息评估。这些结果为用于实施该模型的临床医师评定的仪器评分的有效性提供了证据。(PsycInfo数据库记录(c)2020 APA,保留所有权利)。大多数具有中到大型效果。自我报告和临床医师评价的人格障碍与中小效应量相关。目前的研究纳入了精神科门诊样本中人格的多信息评估。这些结果为用于实施该模型的临床医师评定的仪器评分的有效性提供了证据。(PsycInfo数据库记录(c)2020 APA,保留所有权利)。大多数具有中到大型效果。自我报告和临床医师评价的人格障碍与中小效应量相关。目前的研究纳入了精神科门诊样本中人格的多信息评估。这些结果为用于实施该模型的临床医师评定的仪器评分的有效性提供了证据。(PsycInfo数据库记录(c)2020 APA,保留所有权利)。
更新日期:2020-09-24
down
wechat
bug